Translational Drug Development LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Translational Drug Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013187
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Translational Drug Development LLC (TD2) is a drug development organization offers oncology treatments to cancer patients. The organization offers services which include regulatory affairs services, preclinical services, clinical services, and others. It also offers in vivo services, isogenic cell lines, investigational new drug application services, toxicology support services, medical writing, program analysis, clinical trial management and pancreatic cancer research. The organization also provides non-GLP safety and tolerability, in vitro assays, DMPK services, syngeneic tumor models, orthotopic tumor models, tumor xenograft models, patient-derived tumor xenograft models, and others. TD2 is headquartered in Scottsdale, Arizona, the US.

Translational Drug Development LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Translational Drug Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
PharmaCyte Biotech Partners with Translational Drug Development and Clinical Network Services 10
TD2 Enters into Agreement with Navigating Cancer 11
Forma Therapeutics Enters Into Co-Development Agreement With TGen Drug Development 12
TGen Drug Development Enters Into Co-Development Agreement With Flagship Biosciences 13
TGen Drug Enters Into Co-Development Agreement With Oncoholdings 14
Translational Drug Development LLC – Key Competitors 15
Translational Drug Development LLC – Key Employees 16
Translational Drug Development LLC – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Key Facts 2
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Translational Drug Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Translational Drug Development LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Translational Drug Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PharmaCyte Biotech Partners with Translational Drug Development and Clinical Network Services 10
TD2 Enters into Agreement with Navigating Cancer 11
Forma Therapeutics Enters Into Co-Development Agreement With TGen Drug Development 12
TGen Drug Development Enters Into Co-Development Agreement With Flagship Biosciences 13
TGen Drug Enters Into Co-Development Agreement With Oncoholdings 14
Translational Drug Development LLC, Key Competitors 15
Translational Drug Development LLC, Key Employees 16

★海外企業調査レポート[Translational Drug Development LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magnolia Petroleum Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Grant Thornton International Ltd.:戦略・SWOT・企業財務分析
    Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shionogi & Co., Ltd.:企業の戦略・SWOT・財務分析
    Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • New China Life Insurance Company Ltd.:企業の戦略・SWOT・財務分析
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Mercer LLC:企業のM&A・事業提携・投資動向
    Mercer LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mercer LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Lake Shore Gold Corp.:企業のM&A・事業提携・投資動向
    Lake Shore Gold Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lake Shore Gold Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Arthur J. Gallagher & Co:企業の戦略・SWOT・財務情報
    Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report Summary Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Panera Bread Company:企業の戦略的SWOT分析
    Panera Bread Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Grinners Catering (Australia) Pty Ltd
    Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Banco Bradesco S.A.:企業のM&A・事業提携・投資動向
    Banco Bradesco S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Bradesco S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Genentech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • HSBC Holdings Plc:企業のM&A・事業提携・投資動向
    HSBC Holdings Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HSBC Holdings Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Catasys Inc (CATS):企業の財務・戦略的SWOT分析
    Summary Catasys Inc (Catasys) is a healthcare service provider that offers health and reducing claims costs for health plan members with behavioral health (BH) disorders. The company offers OnTrak, a fifty two week intensive outpatient program, treats an overlooked population and members suffering f …
  • JSC KazMunaiGas Exploration Production:企業のM&A・事業提携・投資動向
    JSC KazMunaiGas Exploration Production - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSC KazMunaiGas Exploration Production Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • China Everbright Limited (165):企業の財務・戦略的SWOT分析
    China Everbright Limited (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • BLS AG:企業の戦略・SWOT・財務情報
    BLS AG - Strategy, SWOT and Corporate Finance Report Summary BLS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Anika Therapeutics Inc (ANIK):企業の製品パイプライン分析2018
    Summary Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regene …
  • AroCell AB (AROC):製薬・医療:M&Aディール及び事業提携情報
    Summary AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the …
  • Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析2018
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect applicat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆